Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -539 | -786 | -1,536 | -8,230 | -15,576 |
| Depreciation Amortization | 4,573 | 2,409 | 8,887 | 6,639 | 4,396 |
| Income taxes - deferred | -189 | -97 | -181 | -187 | -217 |
| Accounts receivable | -4,337 | -3,430 | -977 | -1,825 | -2,346 |
| Accounts payable and accrued liabilities | 4 | -428 | -183 | -669 | 279 |
| Other Working Capital | -9,472 | -12,352 | -4,236 | 5,437 | -9,525 |
| Other Operating Activity | 8,583 | 5,892 | 8,740 | 8,099 | 6,362 |
| Operating Cash Flow | $-1,377 | $-8,792 | $10,514 | $9,264 | $-16,627 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,991 | -720 | -2,918 | -2,170 | -1,700 |
| Purchase Of Investment | -13,682 | -9,750 | -3,904 | N/A | N/A |
| Sale Of Investment | 10,000 | 2,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-5,673 | $-8,470 | $-6,822 | $-2,170 | $-1,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 29,664 | 29,664 | 29,664 |
| Common Stock Issued | 570 | 39 | 1,252 | 803 | 803 |
| Other Financing Activity | -2,024 | -1,088 | -12,510 | -12,480 | -12,461 |
| Financing Cash Flow | $-1,454 | $-1,049 | $18,406 | $17,987 | $18,006 |
| Exchange Rate Effect | 115 | 247 | 323 | 500 | 503 |
| Beginning Cash Position | 41,419 | 41,419 | 18,998 | 18,998 | 18,998 |
| End Cash Position | 33,030 | 23,355 | 41,419 | 44,579 | 19,180 |
| Net Cash Flow | $-8,389 | $-18,064 | $22,421 | $25,581 | $182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,377 | -8,792 | 10,514 | 9,264 | -16,627 |
| Capital Expenditure | -1,991 | -720 | -2,918 | -2,170 | -1,700 |
| Free Cash Flow | -3,368 | -9,512 | 7,596 | 7,094 | -18,327 |